Liquidia Corp current report, 24 March 2021

Liquidia Corporation Form 8-K Summary

Business Context and Reporting Period

Liquidia Corporation filed a Form 8-K dated March 24, 2021, under Item 8.01, “Other Events.” The filing concerns fiscal 2021 compensation arrangements for the company’s non-employee directors.

Key Financial and Equity Metrics

  • No revenue, earnings, cash flow, margin, debt, or liquidity balances are reported in this filing.
  • Each non-employee director waived the annual cash compensation otherwise payable for 2021, intended to extend the company’s cash runway.
  • In lieu of cash compensation, the company granted options covering an aggregate 244,893 common shares.
  • All options have an exercise price of $2.51 per share and were issued under the Liquidia Corporation 2020 Long-Term Incentive Plan.

Material Changes and Compensation Terms

  • Options were granted on March 24, 2021, to seven non-employee directors: Stephen Bloch, Joanna Horobin, Roger Jeffs, Katie Rielly-Gauvin, Arthur Kirsch, Paul Manning, and Raman Singh.
  • Twenty-five percent of each grant vested immediately on March 24, 2021.
  • The remaining shares vest in equal quarterly installments on June 30, September 30, and December 31, 2021, subject to continued service.
  • Each current non-employee director remains entitled to a separate annual option grant of 20,000 shares in 2021 under the company’s director equity compensation policy.

Outlook, Risks, and Unusual Items

The cash-compensation waiver is an unusual compensation action undertaken to preserve cash and extend the company’s cash runway. The filing does not quantify the cash savings, provide updated liquidity guidance, or state whether the waiver materially changes the company’s financial outlook.

Investor Verification Items

  • Verify the amount of cash compensation waived and the resulting expected extension of the company’s cash runway.
  • Confirm the aggregate option grant, individual awards, vesting dates, and $2.51 exercise price.
  • Assess the potential dilution from the 244,893 options and the additional 20,000-share annual grants.
  • Review subsequent filings for changes to director compensation, option vesting, liquidity, or financing needs.